Calendrier des promotions Sandoz Group AG
Calendrier avancé
Graphique simple
À propos de l'entreprise Sandoz Group AG
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. It develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. The company was founded in 1886 and is headquartered in Rotkreuz, Switzerland.| Industry | Pharmaceuticals |
|---|---|
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Дивиденд ао | 0.498 |
| Сайт | https://www.sandoz.com |
| Цена ао | 34.6 |
| Changement de prix par jour: | -1.46% (41.71) |
|---|---|
| Changement de prix par semaine: | -1.2% (41.6) |
| Changement de prix par mois: | -10.55% (45.95) |
| Changement de prix sur 3 mois: | -1.21% (41.605) |
| Changement de prix sur six mois: | +14.68% (35.84) |
| Changement de prix par an: | +31.2% (31.327) |
| Evolution du prix sur 3 ans: | 0% (41.1) |
| Evolution du prix sur 5 ans: | 0% (41.1) |
| Evolution des prix sur 10 ans: | 0% (41.1) |
| Evolution des prix depuis le début de l'année: | -9.89% (45.61) |
|
|
Sous-estimation
|
Efficacité
|
|||||||||||||||||||||||||||||||||||||
Dividendes
|
Devoir
|
Impulsion de croissance
|
|||||||||||||||||||||||||||||||||||||
| Dividende, % | Dividende | Sur la base des résultats de la période | Acheter avant | Date de clôture du registre | Paiement avant |
|---|---|---|---|---|---|
| 0.87% | 0.3 | I кв. 2024 | 01.05.2024 | 03.05.2024 | 20.05.2024 |
| Établissements | Volume | Partager, % |
|---|---|---|
| Fisher Asset Management, LLC | 55602 | 0.01 |
| Mengis Capital Management, Inc. | 15328 | 0 |
| Douglas Lane & Associates, LLC | 13802 | 0 |
| Beddow Capital Management Inc | 13293 | 0 |
| Beach Investment Counsel Inc/pa | 7549 | 0 |
| Yousif Capital Management, LLC | 7528 | 0 |
| Bartlett & Co. | 6963 | 0 |
| Patten & Patten, Inc. | 6527 | 0 |
| Bristol John W & Co Inc /NY/ | 5264 | 0 |
| Boit C F David | 2560 | 0 |
| Superviseur | Titre d'emploi | Paiement | Année de naissance |
|---|---|---|---|
| Mr. Richard Saynor | Chief Executive Officer | N/A | 1967 (58 années) |
| Mr. Asaf Gal | Chief Technology Officer | N/A | 1969 (56 années) |
| Ms. Karen M. King | Head Global Investor Relations | N/A | |
| Ms. Ingrid Sollerer | General Counsel & Chief Compliance Officer | N/A | 1974 (51 année) |
| Ms. Tripti Jha | Chief People Officer | N/A | 1977 (48 années) |
| Mr. Francisco Ballester | President of International | N/A | 1961 (64 année) |
| Mr. Pierre Bourdage | Chief Commercial Officer | N/A | 1979 (46 années) |
| Dr. Glenn A. Gerecke Ph.D. | Chief Manufacturing & Supply Officer | N/A | 1959 (66 années) |
| Mr. Remco J. Steenbergen | Chief Financial Officer | 1968 (57 années) | |
| Ms. Claire D'Abreu-Hayling | Chief Scientific Officer | 1964 (61 année) |
Adresse: Switzerland, Rotkreuz, Suurstoffi 14 - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.sandoz.com
Site web: https://www.sandoz.com
